TickerFactsScreenerDevelopers

Stoke Therapeutics, Inc. (STOK) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $105.40M2019: $222.47M2020: $287.31M2021: $144.90M2022: $113.56M2023: $191.44M2024: $127.98M2025: $84.22M$84.22M
2018Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$84.22M-34.2%
2024$127.98M-33.1%
2023$191.44M+68.6%
2022$113.56M-21.6%
2021$144.90M-49.6%
2020$287.31M+29.1%
2019$222.47M+111.1%
2018$105.40M—